Question Bank › Repeat pull from proven relationships plus room

Repeat pull from proven relationships plus room left

Repeat pull from proven relationships plus room left: the installed base is expanding on its own initiative and is still

Calls Tested
499
Answered YES
37
Hit Rate
7.4%
rare by design

MannKind Corporation (MNKD) — this company's answers

NO on the Q4 2023 call 2024-02-27 C
The model's full reasoning — Q4 2023 call → NO我们根据提供的财报电话会议记录，判断管理层是否描述了现有客户/合作伙伴已经主动增加业务量，并且这些关系仍有很大渗透空间。 关键点： 1. 关于Tyvaso DPI：管理层提到“record revenue for Tyvaso on both royalty and collaboration manufacturing, along with record production on Tyvaso cartridges”，以及“Tyvaso DPI royalty revenue for the fourth quarter was $21 million, which is 132% increase versus 2022”，这表明现有合作伙伴United Therapeutics的订单量在增长（因为这是同一合作伙伴的持续合作）。但这是否是“counterparties' own choice after direct experience”？是的，因为UT在持续增加订单。同时，管理层提到“we are making as much as we can around the clock”和“we know we want to build up inventory”，表明需求强劲。但关于“lightly penetrated”部分，管理层没有明确说现有关系还有多少空间，但提到“Tyvaso DPI has been ahead of all the expectations”以及未来有更多增长潜力。不过，更关键的是，管理层是否明确说这些关系仍处于早期渗透阶段？在回答中，管理层提到“we have multiple shots on goal”和“we are just getting started”，但具体到Tyvaso，没有明确说现有客户还有多少未开发空间。然而，从上下文看，Tyvaso DPI的销售仍在增长，且UT是唯一客户，但管理层没有说“lightly penetrated”这个词。 2. 关于Afrezza：管理层提到“Afrezza net revenue grew $12 million, or 27% year-over-year”和“underlying paid TRx growth of 25%”，这是现有患者需求增长，但这是否是“counterparties' own choice”？是的，患者选择继续使用。但管理层没有明确说这些关系（患者）还有多少空间，而是提到未来有INHALE-1和INHALE-3数据可能扩大市场。但这不是“existing relationships”的深化，而是新数据可能带来新患者。 3. 关于V-Go：管理层提到“V-Go net revenue improved versus the third quarter of 2023 by $0.2 million”，但整体下降，没有明显扩张。 4. 关于合作伙伴：主要是UT，但管理层没有说UT已经“lightly penetrated”，而是说“we are making as much as we can”，暗示产能受限，但需求强劲。但“lightly penetrated”通常指现有客户还有更多可用的量，这里没有明确说。 管理层在回答中多次提到“we are just getting started”和“multiple shots on goal”，但具体到现有关系，没有明确说“这些客户已经主动增加订单，且还有很大空间”。例如，关于Tyvaso，管理层说“we had record production in Q4”和“we'll have hopefully equal record production in Q1”，但这是产能提升，不是客户主动增加订单？实际上，UT的订单量在增加，因为royalty revenue增长132%，这反映了UT的销售增长，而UT是现有合作伙伴，所以这是现有关系的深化。但管理层没有说“lightly penetrated”或“room remains”。 再仔细看，管理层在回答关于Tyvaso竞争时提到“we are making as much as we can around the clock”和“we know we want to build up inventory”，这暗示需求超过供应，但未明确说现有客户还有多少未开发空间。 关于Afrezza，管理层提到“we have been on the market 10 years”和“we are building up US KOL support”，但未说现有患者还有多少空间。 总体来看，管理层描述了现有合作伙伴UT的订单增长（royalty revenue增长），但未明确说这些关系仍“lightly penetrated”。此外，增长主要来自UT的销售增长，但UT是唯一客户，且管理层没有说UT还有多少未开发空间。对于Afrezza，增长来自患者需求，但未说现有患者还有多少空间。 因此，我认为答案应为NO，因为管理层没有明确说现有关系仍处于早期渗透阶段，且没有描述“counterparties' own initiative”的扩张行为，更多是需求增长，但未强调“lightly penetrated”。 但再考虑：管理层说“we have never seen a better time”和“we are just getting started”，但具体到现有关系，没有明确说。所以NO。

← Back to the full MNKD analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that counterparties the company has ALREADY SERVED AND PROVEN ITSELF WITH — existing customers, accounts, partners, members, or programs — are CURRENTLY, ON THEIR OWN INITIATIVE, TAKING OR COMMITTING TO MEANINGFULLY MORE from the company than they previously did (larger or earlier reorders, broader deployments, added sites, products, or scope, relationships stepped up to bigger phases), AND does management convey that these same relationships remain LIGHTLY PENETRATED — that what these counterparties have taken so far is still a small share of what they could take — so that the expansion now visible is early? Answer YES when both halves come through in management's own words as one coherent, present-tense story, in whatever form fits the business: (1) real expansion behavior already occurring in the recent period across more than an isolated account — driven by the counterparties' own choice after direct experience, not by price increases pushed onto unchanged volumes, and not merely contractual auto-renewal; and (2) management conveying, directly or plainly in substance, that substantial room remains inside these same relationships — more sites, volume, scope, or usage those counterparties could still take — with the fuller contribution ahead of the reported results. Answer NO if growth is attributed mainly to new-customer wins with nothing about existing relationships deepening. NO if the expansion is only hoped for, in pipeline, or projected. NO if the deepening rests on a single account or a one-time bulge management expects to fade. NO if management indicates the relationships are already substantially penetrated with little room left. NO if retention or loyalty language is generic with no observed expansion behavior described. NO if the pattern appears only in an analyst's question that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
PPC Pilgrim's Pride Corporation Q1 2024 2024-05-03 A
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
CARS Cars.com Inc. Q1 2023 2023-05-06 B
CALX Calix, Inc. Q1 2023 2023-04-20 C+
TOST Toast, Inc. Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
PI Impinj, Inc. Q4 2022 2023-02-08 B+
DM Desktop Metal, Inc. Q2 2022 2022-08-08 F
FLYW Flywire Corporation Q1 2022 2022-05-14 B+
ZVIA Zevia PBC Q1 2022 2022-05-12 B
FARM Farmer Bros. Co. Q3 2022 2022-05-07 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
ASAN Asana, Inc. Q2 2022 2021-09-01 B+
TENB Tenable Holdings, Inc. Q2 2021 2021-07-27 A
DGX Quest Diagnostics Incorporated Q2 2021 2021-07-22 B+
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
YUM Yum! Brands, Inc. Q2 2018 2018-08-02 C
ORAN Orange SA Q2 2018 2018-07-26 B
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
CVS CVS Health Corporation Q1 2018 2018-05-02 B+
BCOV Brightcove Inc. Q1 2018 2018-04-26 B+
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
CCOI Cogent Communications Holdings, Inc. Q2 2017 2017-08-03 B
PTC PTC Inc. Q3 2017 2017-07-19 C+
WYY WidePoint Corporation Q3 2016 2016-11-09 D
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
WK Workiva Inc. Q4 2015 2016-03-01 B

How the model reasoned

ZVIA · Q1 2022 → YESThe question is about whether management describes existing customers taking more from the company on their own initiative, and that these relationships are still lightly penetrated. YES Management describes existing customers (households and Club channel buyers) already taking meaningfully more through velocity (51% of growth), higher buy rates (+9%), and heavier consumption in the food channel, while conveying that these relationships remain lightly penetrated with substantial room ahead (new households, expanded flavors, broader deployments). This is 100% present-tense, driven by counterparties’ own choice after direct experience, not price hikes or auto-renewal, and the expansion is already occurring across multiple accounts rather than isolated or projected.
PI · Q4 2022 → YESThe question is about whether management describes existing customers expanding their business with the company, and that these relationships are still lightly penetrated. YES The transcript shows management describing existing customers expanding through program expansions, broader deployments, and continued system deployments that are already occurring and expected to drive large volumes in 2023 and beyond, while conveying that these relationships remain lightly penetrated with substantial room for further growth in scope, sites, and usage.
CVS · Q1 2018 → YESThe question is about whether management describes existing customers taking more from the company on their own initiative, and that these relationships are still lightly penetrated. YES The transcript shows management describing existing partnerships (Optum and Cigna clients) already taking more programs through an uptick in CVS Pharmacy and MinuteClinic offerings, driven by the companies' own adoption after experience, with continued opportunities for 2020 and beyond indicating substantial room remains in those relationships.

More from the question bank

Small company, disproportionate current winsThe bottleneck is inside and being paid awayTone of discovery: management sounds newly sExternal validators convergingProfit machinery upgraded while volume stillSelling something whose payoff to the buyer All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.